| In vitro and in vivo models of BBB to evaluate brain targeting drug delivery B Sharma, K Luhach, GT Kulkarni Brain targeted drug delivery system, 53-101, 2019 | 34* | 2019 |
| Attenuation of neurobehavioural abnormalities by papaverine in prenatal valproic acid rat model of ASD K Luhach, GT Kulkarni, VP Singh, B Sharma European Journal of Pharmacology 890, 173663, 2021 | 30 | 2021 |
| Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stress K Luhach, GT Kulkarni, VP Singh, B Sharma Autism Research 14 (11), 2270-2286, 2021 | 26 | 2021 |
| Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder K Luhach, GT Kulkarni, VP Singh, B Sharma Journal of Pharmacy and Pharmacology 73 (11), 1460-1469, 2021 | 14 | 2021 |
| Effect of papaverine on developmental hyperserotonemia induced autism spectrum disorder related behavioural phenotypes by altering markers of neuronal function, inflammation … K Luhach, GT Kulkarni, VP Singh, B Sharma Clinical and Experimental Pharmacology and Physiology 48 (4), 614-625, 2021 | 9 | 2021 |
| Vinpocetine ameliorates developmental hyperserotonemia induced behavioral and biochemical changes: role of neuronal function, inflammation, and oxidative stress K Luhach, G Kulkarni, V Singh, B Sharma Acta Neurobiologiae Experimentalis 82 (1), 35-51, 2022 | 3 | 2022 |
| Vinpocetine, a PDE1 modulator, regulates markers of cerebral health, inflammation, and oxidative stress in a rat model of prenatal alcohol-induced experimental attention … N Sharma, K Luhach, LK Golani, B Singh, B Sharma Alcohol 105, 25-34, 2022 | 2 | 2022 |
| Neuroprotection induced by sulphoraphane in central nervous system disorders P Sharma, K Luhach, N Dhiman, R Awasthi, H Kharkwal, GT Kulkarni, ... Natural Molecules in Neuroprotection and Neurotoxicity, 1815-1838, 2024 | 1 | 2024 |
| Prenatal and Early Life Environmental Stressors: Chemical Moieties Responsible for the Development of Autism Spectrum Disorder K Luhach, P Sharma, N Sharma, N Dhiman, H Kharkwal, B Sharma Neurobiology of Autism Spectrum Disorders, 37-74, 2024 | | 2024 |
| Neuron navigators: A novel frontier with physiological and pathological implications P Sandeep, P Sharma, K Luhach, N Dhiman, H Kharkwal, B Sharma Molecular and Cellular Neuroscience, 103905, 2023 | | 2023 |
| PDE3 inhibition by cilostazol attenuated developmental hyperserotonemia induced behavioural and biochemical deficits in a rat model of autism spectrum disorder K Luhach, B Singh, H Aggarwal, B Sharma Research in Autism Spectrum Disorders 99, 102052, 2022 | | 2022 |
| # 128 Cerebral ischemic conditioning responses: Exploring the potential mechanisms for post stroke neuroprotective benefits A Kaushik, H Aggarwal, K Luhach, P Jain Journal of Pharmaceutical Chemistry 8 (Supplement), 2022 | | 2022 |
| # 129 Targeting central cannabinoid receptors for exploring their potential ischemic preconditioning like P Jain, A Kaushik, H Aggarwal, K Luhach Journal of Pharmaceutical Chemistry 8 (Supplement), 2022 | | 2022 |
| To Study the Role of Pharmacological Modulators of Cyclic Nucleotide Phosphodiesterase Enzyme Family in Experimental Autism Spectrum Disorder K Luhach Noida, 0 | | |
Prof. (Dr.) Bhupesh SharmaProfessor, Department of Pharmaceutical Sciences, Faculty of Life Sciences, Gurugram University在 scientist.com 的电子邮件经过验证
